HS
AMED

HighVista Strategies’s Amedisys AMED Stock Holding History

HighVista Strategies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,250
Closed -$3.86M – 150
2025
Q2 		$3.86M Hold
39,250
– – 1.42% 9
2025
Q1 		$3.64M Hold
39,250
– – 1.4% 8
2024
Q4 		$3.56M Hold
39,250
– – 1.33% 12
2024
Q3 		$3.79M Hold
39,250
– – 1.31% 15
2024
Q2 		$3.6M Hold
39,250
– – 1.32% 15
2024
Q1 		$3.62M Hold
39,250
– – 1.29% 21
2023
Q4 		$3.73M Hold
39,250
– – 1.35% 21
2023
Q3 		$3.67M Buy
+39,250
New +$3.63M 1.7% 12

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HighVista Strategies's AMED Position: Q3 2025 in Review

HighVista Strategies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 39,250 shares — an estimated $3.86M sold.

HighVista Strategies first reported a position in AMED in Q3 2023 and held it in 8 quarters. The position peaked at $3.86M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • HighVista Strategies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • HighVista Strategies sold 39,250 Amedisys shares in Q3 2025, an estimated $3.86M.
  • HighVista Strategies first reported a position in Amedisys in Q3 2023 and held it in 8 quarters.
  • HighVista Strategies's Amedisys position peaked at $3.86M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on HighVista Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.